Early metabolic changes measured by 1H MRS in healthy and dystrophic muscle after injury

Journal of Applied Physiology

Volumn 113, Issue 5, 2012, Pages 808-816

  Xu, Su ^a   Pratt, Stephen J P ^a   Spangenburg, Espen E ^b   Lovering, Richard M ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

Author keywords

Eccentric injury; In vivo magnetic resonance spectroscopy; Mdx; Muscle damage

Indexed keywords

PROTON;

ANIMAL; ANIMAL MUSCULAR DYSTROPHY; ARTICLE; C57BL MOUSE; GENETICS; INJURY; MALE; METABOLISM; MOUSE; MUSCLE ISOMETRIC CONTRACTION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHYSIOLOGY; SKELETAL MUSCLE; TIME; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE;

ANIMALS; ISOMETRIC CONTRACTION; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED MDX; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, ANIMAL; PROTONS; TIME FACTORS;

EID: 84865724877     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.00530.2012     Document Type: Article

References (70)

1. Aldridge R, Cady EB, Jones DA, Obletter G. Muscle pain after exercise is linked with an inorganic phosphate increase as shown by 31P NMR. Biosci Rep 6: 663-667, 1986.
2. Armstrong RB. Initial events in exercise-induced muscular injury. Med Sci Sports Exerc 22: 429-435, 1990. (Pubitemid 20241707)
3. Barany M, Venkatasubramanian PN, Mok E, Siegel IM, Abraham E, Wycliffe ND, Mafee MF. Quantitative and qualitative fat analysis in human leg muscle of neuromuscular diseases by 1H MR spectroscopy in vivo. Magn Reson Med 10: 210-226, 1989. (Pubitemid 19113181)
4. Barash IA, Mathew L, Ryan AF, Chen J, Lieber RL. Rapid musclespecific gene expression changes after a single bout of eccentric contractions in the mouse. Am J Physiol Cell Physiol 286: C355-C364, 2004. (Pubitemid 38146359)
5. Boesch C, Slotboom J, Hoppeler H, Kreis R. In vivo determination of intra-myocellular lipids in human muscle by means of localized 1H-MRspectroscopy. Magn Reson Med 37: 484-493, 1997. (Pubitemid 27146825)
6. Clarkson PM, Nosaka K, Braun B. Muscle function after exerciseinduced muscle damage and rapid adaptation. Med Sci Sports Exerc 24: 512-520, 1992.
7. Conte CD, Tricarico D, Pierno S, Desaphy JF, Liantonio A, Pusch M, Burdi R, Camerino C, Fraysse B, De LA. Taurine and skeletal muscle disorders. Neurochem Res 29: 135-142, 2004. (Pubitemid 38181707)
8. Danielson ER, Ross B. Magnetic Resonance Spectroscopy Diagnosis of Neurological Diseases. New York: Marcel Dekker, 1999.
9. Dawson R Jr, Biasetti M, Messina S, Dominy J. The cytoprotective role of taurine in exercise-induced muscle injury. Amino Acids 22: 309-324, 2002. (Pubitemid 34639590)
10. De Luca A, Pierno S, Tricarico D, Desaphy JF, Liantonio A, Barbieri M, Camerino C, Montanari L, Camerino DC. Taurine and skeletal muscle ion channels. Adv Exp Med Biol 483: 45-56, 2000.
11. Deconinck AE, Rafael JA, Skinner JA, Brown SC, Potter AC, Metzinger L, Watt DJ, Dickson JG, Tinsley JM, Davies KE. Utrophindystrophin- deficient mice as a model for Duchenne muscular dystrophy. Cell 90: 717-727, 1997. (Pubitemid 27357963)
12. DelloRusso C, Crawford RW, Chamberlain JS, Brooks SV. Tibialis anterior muscles in mdx mice are highly susceptible to contraction-induced injury. J Muscle Res Cell Motil 22: 467-475, 2001. (Pubitemid 34264077)
13. DiFranco M, Woods CE, Capote J, Vergara JL. Dystrophic skeletal muscle fibers display alterations at the level of calcium microdomains. Proc Natl Acad Sci USA 105: 14698-14703, 2008.
14. Dunn JF, Bannister N, Kemp GJ, Publicover SJ. Sodium is elevated in mdx muscles: ionic interactions in dystrophic cells. J Neurol Sci 114: 76-80, 1993. (Pubitemid 23025212)
15. Dunn JF, Frostick S, Brown G, Radda GK. Energy status of cells lacking dystrophin: an in vivo/in vitro study of mdx mouse skeletal muscle. Biochim Biophys Acta 1096: 115-120, 1991.
16. Evans GF, Haller RG, Wyrick PS, Parkey RW, Fleckenstein JL. Submaximal delayed-onset muscle soreness: correlations between MR imaging findings and clinical measures. Radiology 208: 815-820, 1998. (Pubitemid 28405122)
17. Fischer LM, daCosta KA, Kwock L, Stewart PW, Lu TS, Stabler SP, Allen RH, Zeisel SH. Sex and menopausal status influence human dietary requirements for the nutrient choline. Am J Clin Nutr 85: 1275-1285, 2007. (Pubitemid 46740469)
18. Fissoune R, Janier M, Briguet A, Hiba B. In vivo assessment of mouse hindleg intramyocellular lipids by 1H-MR spectroscopy. Acad Radiol 16: 890-896, 2009.
19. Friden J, Lieber RL. Structural and mechanical basis of exercise-induced muscle injury. Med Sci Sports Exerc 24: 521-530, 1992.
20. Gannoun-Zaki L, Fournier-Bidoz S, Le CG, Chambon C, Millasseau P, Leger JJ, Dechesne CA. Down-regulation of mitochondrial mRNAs in the mdx mouse model for Duchenne muscular dystrophy. FEBS Lett 375: 268-272, 1995.
21. Goodpaster BH, He J, Watkins S, Kelley DE. Skeletal muscle lipid content and insulin resistance: evidence for a paradox in endurance-trained athletes. J Clin Endocrinol Metab 86: 5755-5761, 2001. (Pubitemid 33152620)
22. Griffiths RD, Cady EB, Edwards RH, Wilkie DR. Muscle energy metabolism in Duchenne dystrophy studied by 31P-NMR: controlled trials show no effect of allopurinol or ribose. Muscle Nerve 8: 760-767, 1985. (Pubitemid 16112663)
23. Hoppeler H. Exercise-induced ultrastructural changes in skeletal muscle. Int J Sports Med 7: 187-204, 1986. (Pubitemid 17185801)
24. Huang Y, Majumdar S, Genant HK, Chan WP, Sharma KR, Yu P, Mynhier M, Miller RG. Quantitative MR relaxometry study of muscle composition and function in Duchenne muscular dystrophy. J Magn Reson Imaging 4: 59-64, 1994.
25. Hughes JD, Johnson NA, Brown SJ, Sachinwalla T, Walton DW, Stannard SR. Effects of eccentric exercise-induced muscle damage on intramyocellular lipid concentration and high energy phosphates. Eur J Appl Physiol 110: 1135-1141, 2010.
26. Huxtable RJ. Physiological actions of taurine. Physiol Rev 72: 101-163, 1992.
27. Hwang JH, Pan JW, Heydari S, Hetherington HP, Stein DT. Regional differences in intramyocellular lipids in humans observed by in vivo 1H-MR spectroscopic imaging. J Appl Physiol 90: 1267-1274, 2001. (Pubitemid 32220908)
28. Ingalls CP, Warren GL, Zhang JZ, Hamilton SL, Armstrong RB. Dihydropyridine and ryanodine receptor binding after eccentric contractions in mouse skeletal muscle. J Appl Physiol 96: 1619-1625, 2004. (Pubitemid 38579983)
29. Kemp GJ, Taylor DJ, Dunn JF, Frostick SP, Radda GK. Cellular energetics of dystrophic muscle. J Neurol Sci 116: 201-206, 1993. (Pubitemid 23176857)
30. Kuhlmann J, Neumann-Haefelin C, Belz U, Kalisch J, Juretschke HP, Stein M, Kleinschmidt E, Kramer W, Herling AW. Intramyocellular lipid and insulin resistance: a longitudinal in vivo 1H-spectroscopic study in Zucker diabetic fatty rats. Diabetes 52: 138-144, 2003. (Pubitemid 36042118)
31. Lamminen AE. Magnetic resonance imaging of primary skeletal muscle diseases: patterns of distribution and severity of involvement. Br J Radiol 63: 946-950, 1990.
32. Le Rumeur E, Le Tallec N, Lewa CJ, Ravalec X, de Certaines JD. In vivo evidence of abnormal mechanical and oxidative functions in the exercised muscle of dystrophic hamsters by 31P-NMR. J Neurol Sci 133: 16-23, 1995.
33. LeBlanc AD, Jaweed M, Evans H. Evaluation of muscle injury using magnetic resonance imaging. Clin J Sport Med 3: 26-30, 1993. (Pubitemid 23088869)
34. Lovering RM, De Deyne PG. Contractile function, sarcolemma integrity, and the loss of dystrophin after skeletal muscle eccentric contractioninduced injury. Am J Physiol Cell Physiol 286: C230-C238, 2004. (Pubitemid 38146346)
35. Lovering RM, Hakim M, Moorman CT III, De Deyne PG. The contribution of contractile pre-activation to loss of function after a single lengthening contraction. J Biomech 38: 1501-1507, 2005. (Pubitemid 40744907)
36. Lovering RM, McMillan AB, Gullapalli RP. Location of myofiber damage in skeletal muscle after lengthening contractions. Muscle Nerve 40: 589-594, 2009.
37. Lovering RM, Michaelson L, Ward CW. Malformed mdx myofibers have normal cytoskeletal architecture yet altered EC coupling and stressinduced Ca2+ signaling. Am J Physiol Cell Physiol 297: C571-C580, 2009.
38. Lovering RM, O'Neill A, Muriel JM, Prosser BL, Strong J, Bloch RJ. Physiology, structure, and susceptibility to injury of skeletal muscle in mice lacking keratin 19-based and desmin-based intermediate filaments. Am J Physiol Cell Physiol 300: C801-C813, 2011.
39. Lovering RM, Roche JA, Bloch RJ, De Deyne PG. Recovery of function in skeletal muscle following 2 different contraction-induced injuries. Arch Phys Med Rehabil 88: 617-625, 2007. (Pubitemid 46627542)
40. Lovering RM, Roche JA, Goodall MH, Clark BB, McMillan A. An in vivo rodent model of contraction-induced injury and non-invasive monitoring of recovery. J Vis Exp 11: 2782, 2011.
41. Marqueste T, Giannesini B, Fur YL, Cozzone PJ, Bendahan D. Comparative MRI analysis of T2 changes associated with single and repeated bouts of downhill running leading to eccentric-induced muscle damage. J Appl Physiol 105: 299-307, 2008.
42. Matsumura K, Nakano I, Fukuda N, Ikehira H, Tateno Y, Aoki Y. Proton spin-lattice relaxation time of Duchenne dystrophy skeletal muscle by magnetic resonance imaging. Muscle Nerve 11: 97-102, 1988. (Pubitemid 18039606)
43. McCully K, Shellock FG, Bank WJ, Posner JD. The use of nuclear magnetic resonance to evaluate muscle injury. Med Sci Sports Exerc 24: 537-542, 1992.
44. McHale MJ, Sarwar ZU, Cardenas DP, Porter L, Salinas AS, Michalek JE, McManus LM, Shireman PK. Increased fat deposition in injured skeletal muscle is regulated by sex-specific hormones. Am J Physiol Regul Integr Comp Physiol 302: R331-R339, 2012.
45. McIntosh L, Granberg KE, Briere KM, Anderson JE. Nuclear magnetic resonance spectroscopy study of muscle growth, mdx dystrophy and glucocorticoid treatments: correlation with repair. NMR Biomed 11: 1-10, 1998. (Pubitemid 28164843)
46. McIntosh LM, Baker RE, Anderson JE. Magnetic resonance imaging of regenerating and dystrophic mouse muscle. Biochem Cell Biol 76: 532- 541, 1998. (Pubitemid 29102039)
47. McIntosh LM, Garrett KL, Megeney L, Rudnicki MA, Anderson JE. Regeneration and myogenic cell proliferation correlate with taurine levels in dystrophin- and MyoD-deficient muscles. Anat Rec 252: 311-324, 1998. (Pubitemid 28440916)
48. McMillan A, Shi D, Pratt SJP, Lovering RM. Diffusion tensor MRI to assess damage in healthy and dystrophic skeletal muscle after lengthening contractions. J Biomed Biotechnol 2011: 970726, 2011.
49. Murphy WA, Totty WG, Carroll JE. MRI of normal and pathologic skeletal muscle. AJR Am J Roentgenol 146: 565-574, 1986. (Pubitemid 16106607)
50. Nurenberg P, Giddings CJ, Stray-Gundersen J, Fleckenstein JL, Gonyea WJ, Peshock RM. MR imaging-guided muscle biopsy for correlation of increased signal intensity with ultrastructural change and delayed-onset muscle soreness after exercise. Radiology 184: 865-869, 1992.
51. Petrof BJ. The molecular basis of activity-induced muscle injury in Duchenne muscular dystrophy. Mol Cell Biochem 179: 111-123, 1998. (Pubitemid 28118846)
52. Petrof BJ, Shrager JB, Stedman HH, Kelly AM, Sweeney HL. Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc Natl Acad Sci USA 90: 3710-3714, 1993. (Pubitemid 23111437)
53. Phoenix J, Betal D, Roberts N, Helliwell TR, Edwards RH. Objective quantification of muscle and fat in human dystrophic muscle by magnetic resonance image analysis. Muscle Nerve 19: 302-310, 1996. (Pubitemid 26069360)
54. Ross B, Michaelis T. Clinical applications of magnetic resonance spectroscopy. Magn Reson Q 10: 191-247, 1994.
55. Roy H, Bhardwaj S, Babu M, Kokina I, Uotila S, Ahtialansaari T, Laitinen T, Hakumaki J, Laakso M, Herzig KH, Yla-Herttuala S. VEGF-A, VEGF-D, VEGF receptor-1, VEGF receptor-2, NF-kappaB, and RAGE in atherosclerotic lesions of diabetic Watanabe heritable hyperlipidemic rabbits. FASEB J 20: 2159-2161, 2006.
56. Schick F, Eismann B, Jung W, Bongers H, Bunse M, Lutz O. Comparison of loclized proton NMR signals of skeletal muscle and fat tissue in vivo: two lipid compartments in muscle tissue. Magn Reson Imaging 29: 158-167, 1993. (Pubitemid 23078508)
57. Schuh RA, Jackson KC, Khairallah RJ, Ward CW, Spangenburg EE. Measuring mitochondrial respiration in intact single muscle fibers. Am J Physiol Regul Integr Comp Physiol 302: R712-R719, 2012.
58. Sharma KR, Mynhier MA, Miller RG. Muscular fatigue in Duchenne muscular dystrophy. Neurology 45: 306-310, 1995.
59. Shellock FG, Fukunaga T, Mink JH, Edgerton VR. Exertional muscle injury: evaluation of concentric versus eccentric actions with serial MR imaging. Radiology 179: 659-664, 1991.
60. Spangenburg EE, Pratt SJP, Wohlers LM, Lovering RM. Use of BODIPY (493/503) to visualize intramuscular lipid droplets in skeletal muscle. J Biomed Biotechnol 2011: 598358, 2011.
61. Stauber WT, Fritz VK, Clarkson PM, Riggs JE. An injury model myopathy mimicking dystrophy: implications regarding the function of dystrophin. Med Hypotheses 35: 358-362, 1991.
62. Straub V, Rafael JA, Chamberlain JS, Campbell KP. Animal models for muscular dystrophy show different patterns of sarcolemmal disruption. J Cell Biol 139: 375-385, 1997. (Pubitemid 27459311)
63. Tinsley JM, Blake DJ, Zuellig RA, Davies KE. Increasing complexity of the dystrophin-associated protein complex. Proc Natl Acad Sci USA 91: 8307-8313, 1994. (Pubitemid 24273653)
64. Torriani M. Measuring muscle lipids with 1H-MR spectroscopy. Skeletal Radiol 36: 607-608, 2007. (Pubitemid 46864001)
65. Walter G, Cordier L, Bloy D, Sweeney HL. Noninvasive monitoring of gene correction in dystrophic muscle. Magn Reson Med 54: 1369-1376, 2005. (Pubitemid 41740766)
66. Warskulat U, Flogel U, Jacoby C, Hartwig HG, Thewissen M, Merx MW, Molojavyi A, Heller-Stilb B, Schrader J, Haussinger D. Taurine transporter knockout depletes muscle taurine levels and results in severe skeletal muscle impairment but leaves cardiac function uncompromised. FASEB J 18: 577-579, 2004.
67. Woods CE, Novo D, DiFranco M, Capote J, Vergara JL. Propagation in the transverse tubular system and voltage dependence of calcium release in normal and mdx muscle fibres. J Physiol 568: 867-880, 2005. (Pubitemid 41646027)
68. Yanagisawa O, Niitsu M, Takahashi H, Goto K, Itai Y. Evaluations of cooling exercised muscle with MR imaging and 31P MR spectroscopy. Med Sci Sports Exerc 35: 1517-1523, 2003. (Pubitemid 37087581)
69. Yatabe Y, Miyakawa S, Ohmori H, Mishima H, Adachi T. Effects of taurine administration on exercise. Adv Exp Med Biol 643: 245-252, 2009.
70. Younkin DP, Berman P, Sladky J, Chee C, Bank W, Chance B. 31P NMR studies in Duchenne muscular dystrophy: age-related metabolic changes. Neurology 37: 165-169, 1987.